Kukafka, R., Pan, S., Silverman, T., Chung, W. K., Terry, M. B., Fleck, E., Younge, R. G., Dimond, J., & Crew, K. D. (2024). Decision Support for Clinician Referral of Patients With Potential BRCA1/2 Mutations for Genetic Counseling. JAMA Network Open, 7(10), e2441175. https://doi.org/10.1001/jamanetworkopen.2024.41175

Siegal, D. M., Tseng, E. K., Schünemann, H. J., Angchaisuksiri, P., Cuker, A., Dane, K. E., DeSancho, M. T., Diuguid, D. L., Griffin, D. O., Klok, F. A., Lee, A. I., Neumann, I., Pai, A., Righini, M., Sanfilippo, K., Terrell, D. R., Akl, E. A., Al Jabiri, R. N., Al Jabiri, Y. N., … Nieuwlaat, R. (2024). ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014219

Rubinstein, G., Izar, B., McDonnell, D. E., Fernandez Valledor, A., Fried, J. A., Clerkin, K., Lin, E. F., Lotan, D., Latif, F., Sayer, G., Uriel, N., & Raikhelkar, J. K. (2024). Recurrent melanoma 25 years after initial diagnosis, presenting as metastatic disease early after heart transplantation. Cardio-Oncology, 10(1). https://doi.org/10.1186/s40959-024-00273-7

Yasin, F., Sokol, E., Vasan, N., Pavlick, D. C., Huang, R. S. P., Pelletier, M., Levy, M. A., Pusztai, L., Lacy, J., Zhang, J. Y., Ross, J. S., & Cecchini, M. (2024). Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations. The Oncologist. https://doi.org/10.1093/oncolo/oyae259

Henry, N. L., Unger, J. M., Vaidya, R., Darke, A. K., Skaar, T. C., Fisch, M. J., & Hershman, D. L. (2024). Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial. Contemporary Clinical Trials, 147, 107712. https://doi.org/10.1016/j.cct.2024.107712

Vaynrub, A., Mishalani, L., Raikhelkar, J., & Crew, K. D. (2024). Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer. Cardio-Oncology, 10(1). https://doi.org/10.1186/s40959-024-00272-8

Gallitto, M., Zhang, X., De Los Santos, G., Wei, H.-J., Fernández, E. C., Duan, S., Sedor, G., Yoh, N., Kokossis, D., Angel, J. C., Wang, Y.-F., White, E., Kinslow, C. J., Berg, X., Tomassoni, L., Zandkarimi, F., Chio, I. I. C., Canoll, P., Bruce, J. N., … Wu, C.-C. (2024). Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae215

Feng, I., Kurlansky, P. A., Powley, T. R., Hynds, M. A., Yang, C. G., Eisenberger, A., Hastie, J. M., Sutherland, L. D., Yuzefpolskaya, M., Colombo, P. C., Sayer, G. T., Uriel, N. Y., Naka, Y., & Takeda, K. (2024). Anti‐factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantation. Artificial Organs. Portico. https://doi.org/10.1111/aor.14885

Le, X., Patel, J. D., Shum, E., Baik, C., Sanborn, R. E., Shu, C. A., Kim, C., Fidler, M. J., Hall, R., Elamin, Y. Y., Tu, J., Blumenschein, G., Zhang, J., Gibbons, D., Gay, C., Mohindra, N. A., Chae, Y., Boumber, Y., Sabari, J., … Heymach, J. V. (2024). A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR-Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial). Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00533

Gu, J., Iyer, A., Wesley, B., Taglialatela, A., Leuzzi, G., Hangai, S., Decker, A., Gu, R., Klickstein, N., Shuai, Y., Jankovic, K., Parker-Burns, L., Jin, Y., Zhang, J. Y., Hong, J., Niu, X., Costa, J. A., Pezet, M. G., Chou, J., … Gaublomme, J. T. (2024). Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap. Nature Biotechnology. https://doi.org/10.1038/s41587-024-02386-x

Shah, N. N., Wang, M., Roeker, L. E., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Inzani, P. L. Z., Alencar, A. J., Ghia, P., Lamanna, N., Hoffmann, M. S., Patel, M. R., Flinn, I., Gerson, J. N., Ma, S., Coombs, C. C., Cheah, C. Y., … Brown, J. R. (2024). Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial. Haematologica. https://doi.org/10.3324/haematol.2024.285754

Sidana, S., Patel, K. K., Peres, L. C., Bansal, R., Kocoglu, M. H., Shune, L., Atrash, S., Smith, K., Midha, S., Ferreri, C. J., Dhakal, B., Dima, D., Costello, P., Wagner, C., Reshef, R., Hosoya, H., Mikkilineni, L., Atanackovic, D., Chhabra, S., … Hansen, D. K. (2024). Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma. Blood Journal. https://doi.org/10.1182/blood.2024025945

Janivara, R., Chen, W. C., Hazra, U., Baichoo, S., Agalliu, I., Kachambwa, P., Simonti, C. N., Brown, L. M., Tambe, S. P., Kim, M. S., Harlemon, M., Jalloh, M., Muzondiwa, D., Naidoo, D., Ajayi, O. O., Snyper, N. Y., Niang, L., Diop, H., Ndoye, M., … Rebbeck, T. R. (2024). Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa. Nature Genetics, 56(10), 2093–2103. https://doi.org/10.1038/s41588-024-01931-3

Lichtenstein, M. R. L., Campbell, P., Raghunathan, R., Beauchemin, M., Elkin, E. B., Crew, K. D., Accordino, M., Ippoliti, C., Hwang, M., Abramova, R., Harden, E., Kelly, P., Collins, N., Faheem, K., Wright, J. D., & Hershman, D. L. (2024). Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs. JCO Oncology Practice. https://doi.org/10.1200/op.24.00326

Pope, L. G., Abedin, Z., Crew, K. D., Kukafka, R., & Pincus, H. A. (2024). Developing decision support tools for high-risk women and healthcare providers to increase chemoprevention informed choice and uptake: A retrospective translational science case study. Journal of Clinical and Translational Science, 8(1). https://doi.org/10.1017/cts.2024.565

Thomas, A. S., Tehranifar, P., Kwon, W., Shridhar, N., Sugahara, K. N., Schrope, B. A., Chabot, J. A., Manji, G. A., Genkinger, J. M., & Kluger, M. D. (2024). Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Journal of Surgical Oncology. Portico. https://doi.org/10.1002/jso.27851

Abate-Shen, C. (2024). Context-specific targeting of the androgen receptor in prostate cancer. Nature Genetics, 56(10), 2000–2001. https://doi.org/10.1038/s41588-024-01935-z

Lamanna, N., Tam, C. S., Woyach, J. A., Alencar, A. J., Palomba, M. L., Zinzani, P. L., Flinn, I. W., Fakhri, B., Cohen, J. B., Kontos, A., Konig, H., Ruppert, A. S., Chatterjee, A., Sizelove, R., Compte, L., Tsai, D. E., & Jurczak, W. (2024). Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy. EJHaem, 5(5), 929–939. Portico. https://doi.org/10.1002/jha2.1013

Soler-Sáez, I., Karz, A., Hidalgo, M. R., Gómez-Cabañes, B., López-Cerdán, A., Català-Senent, J. F., Prutisto-Chang, K., Eskow, N. M., Izar, B., Redmer, T., Kumar, S., Davies, M. A., de la Iglesia-Vayá, M., Hernando, E., & García-García, F. (2024). Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.09.005

Michel, A. M., Yi, H., Amenta, J., Collins, N., Vaynrub, A., Umakanth, S., Anderson, G., Arnold, K., Law, C., Pruthi, S., Sandoval-Leon, A., Shirley, R., Perdekamp, M. G., Colonna, S., Krisher, S., King, T., Yee, L. D., Ballinger, T. J., Braun-Inglis, C., … Kukafka, R. (2024). Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904). BMC Medical Informatics and Decision Making, 24(1). https://doi.org/10.1186/s12911-024-02691-0

Abdulbaseer, U., Piracha, N., Hamouda, M., Farajallah, I., Abdul-Majid, S., Abdelwahab, S., Teltser, W. K., & Padela, A. I. (2024). Muslim Patients’ Religious & Spiritual Resource Needs in US Hospitals: Findings from a National Survey. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-024-08960-y

Zhukovsky, S., White, J., Chakraborty, R., Costa, L. J., Van Oekelen, O., Sborov, D. W., Cliff, E. R. S., & Mohyuddin, G. R. (2024). Multiple myeloma clinical trials exclude patients with the highest-risk disease: a systematic review of trial exclusion criteria. Leukemia & Lymphoma, 1–10. https://doi.org/10.1080/10428194.2024.2395440

Brown, J. R., Eichhorst, B., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Jurczak, W., Zhou, K., Šimkovič, M., Mayer, J., Gillespie-Twardy, A., Ferrajoli, A., Ganly, P. S., Weinkove, R., Grosicki, S., Mital, A., Robak, T., Osterborg, A., Yimer, H. A., … Shadman, M. (2024). Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE. Blood Journal. https://doi.org/10.1182/blood.2024024667

Neugut, A. I., & Bates, S. E. (2024). Highlights of ASCO 2024. The Oncologist, 29(11), 913–917. https://doi.org/10.1093/oncolo/oyae250

Kwan, M. L., Pimentel, N., Izano, M., Iribarren, C., Rana, J. S., Nguyen-Huynh, M., Cheng, R., Laurent, C. A., Lee, V. S., Roh, J. M., Rillamas-Sun, E., Hershman, D. L., Kushi, L. H., Greenlee, H., & Neugebauer, R. (2024). Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLOS ONE, 19(9), e0310531. https://doi.org/10.1371/journal.pone.0310531

Chen, L. N., Keating, C., Leb, J., Saqi, A., & Shu, C. A. (2024). Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer. Respiratory Medicine Case Reports, 51, 102091. https://doi.org/10.1016/j.rmcr.2024.102091

Wu, L. W., Jang, S. J., Shapiro, C., Fazlollahi, L., Wang, T. C., Ryeom, S. W., & Moy, R. H. (2024). Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics. Targeted Oncology, 19(6), 845–865. https://doi.org/10.1007/s11523-024-01097-2

Dallos, M. C., Obradovic, A. Z., McCann, P., Chowdhury, N., Pratapa, A., Aggen, D. H., Gaffney, C., Autio, K. A., Virk, R. K., De Marzo, A. M., Antonarakis, E. S., Scher, H. I., Drake, C. G., & Rathkopf, D. E. (2024). Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer. Clinical Cancer Research, 30(22), 5218–5230. https://doi.org/10.1158/1078-0432.ccr-24-0060

Sudunagunta, V. S., & Viny, A. D. (2024). Untangling the loops of STAG2 mutations in myelodysplastic syndrome. Leukemia & Lymphoma, 1–10. https://doi.org/10.1080/10428194.2024.2400210

Lopez-Bujanda, Z. A., Hadavi, S. H., Ruiz De Porras, V., Martínez-Balibrea, E., & Dallos, M. C. (2024). Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets. Chemokine Receptors in Health and Disease, 162–205. https://doi.org/10.1016/bs.ircmb.2024.03.008

Bazarbachi, A.-H., Avet-Loiseau, H., Harousseau, J.-L., Bazarbachi, A., & Mohty, M. (2024). Precision medicine for multiple myeloma: The case for translocation (11;14). Cancer Treatment Reviews, 130, 102823. https://doi.org/10.1016/j.ctrv.2024.102823

Chen, Y., Su, Y., Cao, X., Siavelis, I., Leo, I. R., Zeng, J., Tsagkozis, P., Hesla, A. C., Papakonstantinou, A., Liu, X., Huang, W., Zhao, B., Haglund, C., Ehnman, M., Johansson, H., Lin, Y., Lehtiö, J., Zhang, Y., Larsson, O., … de Flon, F. H. (2024). Molecular Profiling Defines Three Subtypes of Synovial Sarcoma. Advanced Science, 11(41). Portico. https://doi.org/10.1002/advs.202404510

Bhutani, D., Liu, Y., Chakraborty, R., Radhakrishnan, J., Lentzsch, S., Peters, D., & Rubinstein, S. (2024). Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease. British Journal of Haematology, 205(5), 1860–1865. Portico. https://doi.org/10.1111/bjh.19748

Kakkilaya, A., Trando, A., Cliff, E. R. S., Mian, H., Al Hadidi, S., Aziz, M., Goodman, A. M., Jeong, A.-R., Smith, W. L., Kelkar, A. H., Russler-Germain, D. A., Mehra, N., Chakraborty, R., Gertz, M. A., & Mohyuddin, G. R. (2024). Evaluating early intervention in smoldering myeloma clinical trials: a systematic review. The Oncologist. https://doi.org/10.1093/oncolo/oyae219

Jhaveri, K. L., Accordino, M. K., Bedard, P. L., Cervantes, A., Gambardella, V., Hamilton, E., Italiano, A., Kalinsky, K., Krop, I. E., Oliveira, M., Schmid, P., Saura, C., Turner, N. C., Varga, A., Cheeti, S., Hilz, S., Hutchinson, K. E., Jin, Y., Royer-Joo, S., … Juric, D. (2024). Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology, 42(33), 3947–3956. https://doi.org/10.1200/jco.24.00110

Li, C. Y., Rosenblat, T. L., Husain, S., Silvers, D. N., Khandji, A. G., Ben-Dov, M., Odel, J. G., & Wesley, S. F. (2024). Sweet Syndrome in the Central Nervous System: A Case of Orbital Inflammation, Sixth Nerve Palsy, and Pachymeningitis. Journal of Neuro-Ophthalmology. https://doi.org/10.1097/wno.0000000000002256

Nicolson, N. G., Tandurella, J. A., Wu, L. W., Patel, J., Morris, E., Seppälä, T. T., Guinn, S., Zlomke, H., Shubert, C. R., Lafaro, K. J., Burns, W. R., Cameron, J. L., He, J., Fertig, E. J., Jaffee, E. M., Zimmerman, J. W., & Burkhart, R. A. (2024). Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma. Annals of Surgery. https://doi.org/10.1097/sla.0000000000006517

Grattoni, A., Korbutt, G., Tomei, A. A., García, A. J., Pepper, A. R., Stabler, C., Brehm, M., Papas, K., Citro, A., Shirwan, H., Millman, J. R., Melero-Martin, J., Graham, M., Sefton, M., Ma, M., Kenyon, N., Veiseh, O., Desai, T. A., Nostro, M. C., … de Vos, P. (2024). Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-01029-0

Goyal, A., O’Leary, D., Dabaja, B., Weng, W.-K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N., … Foss, F. (2024). ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and Cellular Therapy, 30(11), 1047–1060. https://doi.org/10.1016/j.jtct.2024.08.020

Rios, C. A. O., Qayed, M., Etra, A. M., Reshef, R., Newcomb, R., Yuhasz, N., Hexner, E. O., Aguayo-Hiraldo, P., Merli, P., Hogan, W. J., Weber, D., Kitko, C. L., Ayuk, F., Eder, M., Grupp, S. A., Kraus, S., Sandhu, K., Ullrich, E., Vasova, I., … Akahoshi, Y. (2024). Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Transplantation and Cellular Therapy, 30(11), 1061.e1-1061.e10. https://doi.org/10.1016/j.jtct.2024.08.019

Wierda, W. G., Shah, N. N., Cheah, C. Y., Lewis, D., Hoffmann, M. S., Coombs, C. C., Lamanna, N., Ma, S., Jagadeesh, D., Munir, T., Wang, Y., Eyre, T. A., Rhodes, J. M., McKinney, M., Lech-Maranda, E., Tam, C. S., Jurczak, W., Izutsu, K., Alencar, A. J., … Ghia, P. (2024). Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study. The Lancet Haematology, 11(9), e682–e692. https://doi.org/10.1016/s2352-3026(24)00172-8

Rathkopf, D. E., Patel, M. R., Choudhury, A. D., Rasco, D., Lakhani, N., Hawley, J. E., Srinivas, S., Aparicio, A., Narayan, V., Runcie, K. D., Emamekhoo, H., Reichert, Z. R., Nguyen, M. H., Wells, A. L., Kandimalla, R., Liu, C., Suryawanshi, S., Han, J., Wu, J., … Armstrong, A. J. (2024). Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer. Annals of Oncology. https://doi.org/10.1016/j.annonc.2024.09.005

Apolo, A. B., Girardi, D. M., Niglio, S. A., Nadal, R., Kydd, A. R., Simon, N., Ley, L., Cordes, L. M., Chandran, E., Steinberg, S. M., Lee, S., Lee, M.-J., Rastogi, S., Sato, N., Cao, L., Banday, A. R., Boudjadi, S., Merino, M. J., Toubaji, A., … Mortazavi, A. (2024). Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of Clinical Oncology, 42(25), 3033–3046. https://doi.org/10.1200/jco.23.02233

Di Bona, M., Chen, Y., Agustinus, A. S., Mazzagatti, A., Duran, M. A., Deyell, M., Bronder, D., Hickling, J., Hong, C., Scipioni, L., Tedeschi, G., Martin, S., Li, J., Ruzgaitė, A., Riaz, N., Shah, P., D’Souza, E. K., Brodtman, D. Z., Sidoli, S., … Bakhoum, S. F. (2024). Micronuclear collapse from oxidative damage. Science, 385(6712). https://doi.org/10.1126/science.adj8691

Chakraborty, R., Zanwar, S., Hegenbart, U., Bhutani, D., Gertz, M. A., Dispenzieri, A., Kumar, S. K., D’Souza, A., Patwari, A., Cowan, A. J., Chen, G., Milani, P., Palladini, G., Sanchorawala, V., Bodanapu, G., Schönland, S., Lentzsch, S., & Muchtar, E. (2024). Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy. Blood Journal. https://doi.org/10.1182/blood.2024025899

Spira, A., Girard, N., Krebs, M., Park, K., Shu, C., Dougherty, L., & Cho, B. C. (2023). A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab. Future Oncology, 19(33), 2213–2225. https://doi.org/10.2217/fon-2023-0284

Figg, W. D., & Bates, S. E. (2024). Clinical trial results: each patient’s participation should count. The Oncologist. https://doi.org/10.1093/oncolo/oyae252

Rekhtman, N., Tischfield, S. E., Febres-Aldana, C. A., Lee, J. J.-Koo., Chang, J. C., Herzberg, B. O., Selenica, P., Woo, H. J., Vanderbilt, C. M., Yang, S.-R., Xu, F., Bowman, A. S., da Silva, E. M., Noronha, A. M., Mandelker, D. L., Mehine, M., Mukherjee, S., Blanco-Heredia, J., Orgera, J. J., … Rudin, C. M. (2024). Chromothripsis-mediated small cell lung carcinoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-24-0286

Leuva, H., Zhou, M., Jamaleddine, N., Meseha, M., Faiena, I., Anna Park, Y.-H., McWilliams, G., Luhrs, C., Maxwell, K. N., Von Hoff, D., Bates, S. E., & Fojo, T. (2024). Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses. EBioMedicine, 107, 105288. https://doi.org/10.1016/j.ebiom.2024.105288

Suzuki, Y., Chen, L., Matsuo, K., Ferris, J. S., Elkin, E. B., Melamed, A., Kong, C. Y., Bickell, N., Myers, E. R., Havrilesky, L. J., Xu, X., Blank, S. V., Hazelton, W. D., Hershman, D. L., & Wright, J. D. (2024). Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecologic Oncology, 190, 78–83. https://doi.org/10.1016/j.ygyno.2024.08.003